Israel Biotech Fund
Steven Nichtberger is a Venture Advisor at Israel Biotech Fund. Steven is also the Co-founder, Chairman, & CEO of Cabaletta Bio. He was former Head of Marketing, Merck. A serial entrepreneur with 20 years of healthcare and industry experience focused on developing and commercializing breakthrough medical advances. Dr. Nichtberger is an Adjunct Professor at Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.